Texas 2025 89th Regular

Texas House Bill HB3078 Fiscal Note / Fiscal Note

Filed 04/12/2025

                    LEGISLATIVE BUDGET BOARD     Austin, Texas       FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION             April 12, 2025       TO: Honorable Gary VanDeaver, Chair, House Committee on Public Health     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: HB3078 by Darby (Relating to manufacturer fees for operation of a real-time electronic logging system to track over-the-counter sales of ephedrine, pseudoephedrine, or norpseudoephedrine; imposing a fee; authorizing an administrative penalty.), As Introduced     No significant fiscal implication to the State is anticipated. It is assumed that any costs associated with the bill could be absorbed using existing resources.The bill would authorize the Department of State Health Services to impose an administrative penalty against manufacturers that fail to pay the required fee. It is assumed that any revenue implications associated with the bill would be insignificant.  Local Government ImpactNo significant fiscal implication to units of local government is anticipated.  Source Agencies: b > td > 304 Comptroller of Public Accounts, 537 State Health Services, Department of  LBB Staff: b > td > JMc, NPe, ER, APA

LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION
April 12, 2025

 

 

  TO: Honorable Gary VanDeaver, Chair, House Committee on Public Health     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: HB3078 by Darby (Relating to manufacturer fees for operation of a real-time electronic logging system to track over-the-counter sales of ephedrine, pseudoephedrine, or norpseudoephedrine; imposing a fee; authorizing an administrative penalty.), As Introduced   

TO: Honorable Gary VanDeaver, Chair, House Committee on Public Health
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: HB3078 by Darby (Relating to manufacturer fees for operation of a real-time electronic logging system to track over-the-counter sales of ephedrine, pseudoephedrine, or norpseudoephedrine; imposing a fee; authorizing an administrative penalty.), As Introduced

 Honorable Gary VanDeaver, Chair, House Committee on Public Health

 Honorable Gary VanDeaver, Chair, House Committee on Public Health

 Jerry McGinty, Director, Legislative Budget Board 

 Jerry McGinty, Director, Legislative Budget Board 

 HB3078 by Darby (Relating to manufacturer fees for operation of a real-time electronic logging system to track over-the-counter sales of ephedrine, pseudoephedrine, or norpseudoephedrine; imposing a fee; authorizing an administrative penalty.), As Introduced 

 HB3078 by Darby (Relating to manufacturer fees for operation of a real-time electronic logging system to track over-the-counter sales of ephedrine, pseudoephedrine, or norpseudoephedrine; imposing a fee; authorizing an administrative penalty.), As Introduced 



No significant fiscal implication to the State is anticipated.

No significant fiscal implication to the State is anticipated.

It is assumed that any costs associated with the bill could be absorbed using existing resources.The bill would authorize the Department of State Health Services to impose an administrative penalty against manufacturers that fail to pay the required fee. It is assumed that any revenue implications associated with the bill would be insignificant.



The bill would authorize the Department of State Health Services to impose an administrative penalty against manufacturers that fail to pay the required fee. It is assumed that any revenue implications associated with the bill would be insignificant.

 Local Government Impact

No significant fiscal implication to units of local government is anticipated.

Source Agencies: b > td > 304 Comptroller of Public Accounts, 537 State Health Services, Department of

304 Comptroller of Public Accounts, 537 State Health Services, Department of

LBB Staff: b > td > JMc, NPe, ER, APA

JMc, NPe, ER, APA